Company intelligence / Profile preview
Cypress Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
Overview
Cypress Pharmaceuticals was a specialty pharmaceutical company based in Madison, Mississippi, that focused on the development and commercialization of generic and branded prescription products. The company's portfolio primarily targeted therapeutic areas such as cough and cold, nutritional supplements, and pain management. In 2013, Cypress and its subsidiary Hawthorn Pharmaceuticals were acquired by Pernix Therapeutics for approximately $101 million. Following the acquisition, its operations were integrated into Pernix, which later faced financial restructuring and asset sales.
- Therapeutic areas
- NeurologyPulmonologyInfectious DiseasesMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Cypress Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cypress Pharmaceuticals.